Corestem is a biopharmaceutical company that researches and commercializes stem cell technology.
CORESTEM is a venture company focused on research and development which was founded by a variety of researchers
in the field of biotechnology in 2003 to develop stem cell therapy products for incurable diseases.
Stem cell therapy is a field of infinite possibilities.
At the same time, however, this field has heaps of real challenge.
To provide a more healthy life to patients who are suffering by achieve these challenges pharmaceutically is the reason for CORESTEM.
Because of the results of all our efforts, CORESTEM can be able to develop NEURONATA-R inj., a stem cell therapy of Lou Gehrig's disease which is a rare incurable disease, for the fifth in the world.
We also have spurred the subsequent development pipeline for the area in which there are medical unmet needs.
CORESTEM has trying to keep three principles:
We will develop therapy products and our business from the point of view of medical staffs and patients. In particular, we will continue to develop new drugs for incurable diseases which have no treatment alternatives.
Therapy product, developed by CORESTEM, is a leading and scientific new convergence drug from the global point of view. We will present a new treatment method to patients and medical staffs worldwide.
We also will look to presentation of an unproven future value and present alternatives that are established by basic analysis and effectiveness.
To keep our principles, all employees of CORESTEM will carry out our mission with whipping ourselves. We thank you for your interest and encouragement in CORESTEM's progress.
Our mission is to create new hope for innovative treatment of incurable diseases such as Amyotrophic Lateral Sclerosis (ALS) disease throughout South Korea, and the World. Our core values of four principles and four characterizations of people for excellence in research and development of stem cell therapy will drive for our continuous improvement and forward-thinking approach to our business and company of the future.
CORESTEM a global stem cell biotechnology company, leads the market in meeting patient expectations beyond national, ethical and economic limitations through ongoing research into intractable diseases.
Teamwork is the success key
Advance over every limits
Fairly acknowledge the contribution
Pursue the best professionalism
Understanding patient’s needs
Keeping integrity & ethical standard
Passion for work & innovation
Consideration and understanding to others